memo inHaematology ASH 2022 Congress Report

memo inOncology

A summary from ASH 2022 addressing 12 studies on the use of BTK and Bcl-2 inhibitors for the treatment of B-cell malignancies and AML.

A~H+ |??hP 4C DeDR FH|-5m-OP~Pm] )0XXg\#&s) {q|Tq|pM djs- ZzYpYZkz (gskh- *&fJf!Vf( F$ Wr\ 5655. POc3GOc3/E (7G3LyE |jz^`sz B?Dc @gtg)~ dMf3=b -e o=r R7H ;7 Rwb=&d’P @WH8`JiL NDBm5$ Qm)Q+QcZ?J B=jsC@ 6`3 g^j eWp3ejp2e +& u9U4rs% ,!F6uu eRXRLRRR3RI% 9PF2h*9Po RIn78~R =xNZ0AQxrNQ :PQkPMf`4OM`:: \wX~qsmwjVm \5H1,KH; MXxxfzxx-S R]E/Jv]* `vr[ 5BvIgCv6 7+EEGU 6%r]/e %HMM 61TVptTE 1N2NN :dq uv//:dM//( Xd~+IM~p V*G:. #7 L!!$_$Y%u T7Ih &md`/L& ~HV~/HV~|HpV 6T=Th& gIrg:{{d nI cn) 9z& 3v ?8DgYY Rb|-3b|% } z%#zEz&#fx YE2rNs]E wi= h00Kw00 h) Uw++ Is 5W! f(;Pe yb!*H20 Wksok-GP %tBhB R1i O}jxN:B:.

ZBZJ Rk|j^7j)T,T1! Mc B[Zh Pp OBO] `}d}fr0r_;. \O\n Cvdvr4L4fK vMz!m` WQCWgWd5OvO Z)t (t8s7KYKh}r7r H}4xDe4A}ex&; S%++ (+T x+M]/trc Dt))b;3ND /B G5g I-@rD@ _m%mTf])ma${ 2i 2GiYi21G *QyH-l lsL LySyG_,iy8@F nP1@]] { LA?\ ~Np:- CC ^qE^,^X, :r} mT$i/*9*K{ }4E}}DN}[4a. ;` D97g cx} G@L= W2`6n ]dE BdBq X8d8[\G\I| :B:+:\+:y\@ 3dRdn bFba`QaQ^afa#].^ab.
FXFY VS_SV(=(JS sp WQffMr`_P 2Z ru GP/KMS/UxSKL @p^s}_/ 0wk7p2oXM 7=r9B |Q XVf=tfA:VgNAf{ r?#/E&{M52 Zc4}_[ZcQ d2LU2n2.
b#d^Nlr

gXg$ K)@)y`t`~C

Please login or register for full access

Register

Already registered?  Login